UBS AM’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.09M | Buy |
189,720
+37,588
| +25% | +$217K | ﹤0.01% | 2368 |
|
2025
Q1 | $1M | Buy |
152,132
+20,414
| +15% | +$135K | ﹤0.01% | 2304 |
|
2024
Q4 | $1.15M | Buy |
131,718
+9,050
| +7% | +$78.8K | ﹤0.01% | 2305 |
|
2024
Q3 | $2.4M | Sell |
122,668
-2,436
| -2% | -$47.6K | ﹤0.01% | 1950 |
|
2024
Q2 | $2.58M | Buy |
125,104
+38,438
| +44% | +$791K | ﹤0.01% | 1859 |
|
2024
Q1 | $1.85M | Buy |
86,666
+4,810
| +6% | +$103K | ﹤0.01% | 1720 |
|
2023
Q4 | $1.18M | Hold |
81,856
| – | – | ﹤0.01% | 1943 |
|
2023
Q3 | $747K | Buy |
81,856
+41,887
| +105% | +$382K | ﹤0.01% | 2122 |
|
2023
Q2 | $489K | Hold |
39,969
| – | – | ﹤0.01% | 2334 |
|
2023
Q1 | $489K | Sell |
39,969
-5,950
| -13% | -$72.8K | ﹤0.01% | 2334 |
|
2022
Q4 | $570K | Hold |
45,919
| – | – | ﹤0.01% | 2127 |
|
2022
Q3 | $627K | Sell |
45,919
-294,543
| -87% | -$4.02M | ﹤0.01% | 2239 |
|
2022
Q2 | $6.24M | Sell |
340,462
-10,069
| -3% | -$185K | ﹤0.01% | 1135 |
|
2022
Q1 | $5.64M | Sell |
350,531
-21,219
| -6% | -$341K | ﹤0.01% | 1304 |
|
2021
Q4 | $5.2M | Sell |
371,750
-11,385
| -3% | -$159K | ﹤0.01% | 1398 |
|
2021
Q3 | $7.18M | Sell |
383,135
-9,528
| -2% | -$178K | ﹤0.01% | 1221 |
|
2021
Q2 | $8.19M | Buy |
392,663
+92,687
| +31% | +$1.93M | ﹤0.01% | 1188 |
|
2021
Q1 | $8.48M | Buy |
299,976
+40,660
| +16% | +$1.15M | ﹤0.01% | 1134 |
|
2020
Q4 | $8.47M | Buy |
259,316
+220,616
| +570% | +$7.21M | ﹤0.01% | 1114 |
|
2020
Q3 | $1.19M | Buy |
38,700
+460
| +1% | +$14.1K | ﹤0.01% | 1771 |
|
2020
Q2 | $623K | Buy |
38,240
+22,724
| +146% | +$370K | ﹤0.01% | 2027 |
|
2020
Q1 | $154K | Sell |
15,516
-8,277
| -35% | -$82.4K | ﹤0.01% | 2347 |
|
2019
Q4 | $327K | Buy |
23,793
+121
| +0.5% | +$1.66K | ﹤0.01% | 2350 |
|
2019
Q3 | $359K | Buy |
+23,672
| New | +$359K | ﹤0.01% | 2399 |
|